Natixis Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Natixis Advisors’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-24,665	Closed	-$794K	–	1585
2024 Q2	$794K	Sell	24,665 -3,284	-12%	-$114K	﹤0.01%	1317
2024 Q1	$1.08M	Buy	27,949 +63	+0.2%	+$2.2K	﹤0.01%	1192
2023 Q4	$858K	Sell	27,886 -26,473	-49%	-$663K	﹤0.01%	1252
2023 Q3	$1.22M	Buy	54,359 +32,865	+153%	+$750K	﹤0.01%	1125
2023 Q2	$462K	Buy	+21,494	New	+$488K	﹤0.01%	1355
2020 Q4	–	Sell	-90,189	Closed	-$1.88M	–	1218
2020 Q3	$1.88M	Buy	90,189 +5,100	+6%	+$92.1K	0.01%	809
2020 Q2	$1.49M	Buy	85,089 +10,751	+14%	+$210K	0.01%	877
2020 Q1	$1.21M	Buy	+74,338	New	+$1.53M	0.01%	856

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Natixis Advisors's COLL Position: Q3 2024 in Review

Natixis Advisors sold out of Collegium Pharmaceutical (COLL) in Q3 2024, closing a stake of 24,665 shares — an estimated $794K sold.

Natixis Advisors first reported a position in COLL in Q1 2020 and held it in 8 quarters. The position peaked at $1.88M in Q3 2020. 249 funds tracked by Wall St. Rank hold COLL as of Q3 2024.

Natixis Advisors reported no remaining Collegium Pharmaceutical position as of Q3 2024 after selling out during the quarter.
Natixis Advisors sold 24,665 Collegium Pharmaceutical shares in Q3 2024, an estimated $794K.
Natixis Advisors first reported a position in Collegium Pharmaceutical in Q1 2020 and held it in 8 quarters.
Natixis Advisors's Collegium Pharmaceutical position peaked at $1.88M in Q3 2020.
249 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2024.

Based on Natixis Advisors's 13F filing for Q3 2024, filed 6 Nov 2024.